Importantly, 17-Octadecynoic acid may act as an enzyme inhibitor and has anti-cancer potential, which could contribute to the regulation of apoptotic markers (Casp3, Casp9) and suppression of DBP-induced cell death. This evidence concerns the gene CASP9 and cancer.